Peter H. Rheinstein

1.0k total citations
89 papers, 612 citations indexed

About

Peter H. Rheinstein is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Peter H. Rheinstein has authored 89 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Physiology. Recurrent topics in Peter H. Rheinstein's work include Glioma Diagnosis and Treatment (7 papers), Cancer-related cognitive impairment studies (6 papers) and Tryptophan and brain disorders (6 papers). Peter H. Rheinstein is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer-related cognitive impairment studies (6 papers) and Tryptophan and brain disorders (6 papers). Peter H. Rheinstein collaborates with scholars based in United States, United Kingdom and Switzerland. Peter H. Rheinstein's co-authors include Steven Lehrer, Kenneth E. Rosenzweig, Steven Lehrer, Michael B. Mazis, Sheryl Green, K. Rosenzweig, Francine R. Dembitzer, Richard L. Oliver, Timothy Morello and James Schmeidler and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter H. Rheinstein

81 papers receiving 577 citations

Peers

Peter H. Rheinstein

PRM

PHYSI

IMMUN

Hao Nie China

Caroline Barau France

Fen Tang China

Lanyu Zhang United States

Shiqi Gao China

Jun Fan China

Vasiliki Georgakopoulou Greece

Shengyuan Liu China

Elena Tremoli Italy

Hao Nie China

Peter H. Rheinstein

113 ×0.8

117 ×0.9

54 ×0.8

PRM

57 ×0.8

PHYSI

90 ×1.5

IMMUN

Citations per year, relative to Peter H. Rheinstein Peter H. Rheinstein (= 1×) peers Hao Nie

Countries citing papers authored by Peter H. Rheinstein

Since Specialization

Citations

This map shows the geographic impact of Peter H. Rheinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Rheinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Rheinstein more than expected).

Fields of papers citing papers by Peter H. Rheinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Rheinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Rheinstein. The network helps show where Peter H. Rheinstein may publish in the future.

Co-authorship network of co-authors of Peter H. Rheinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Rheinstein. A scholar is included among the top collaborators of Peter H. Rheinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Rheinstein. Peter H. Rheinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehrer, Steven & Peter H. Rheinstein. (2025). Klebsiella pneumoniae infection increases risk of Alzheimer's disease in the UK Biobank cohort. Psychogeriatrics. 25(2). e70013–e70013.

Lehrer, Steven & Peter H. Rheinstein. (2025). Re: Association of immunoglobulin E levels with glioma risk and survival. JNCI Journal of the National Cancer Institute. 117(3). 565–566. 1 indexed citations

Lehrer, Steven & Peter H. Rheinstein. (2024). Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer. American Journal of Clinical Oncology. 47(12). 591–594. 3 indexed citations

Lehrer, Steven & Peter H. Rheinstein. (2023). RORB, an Alzheimer’s disease susceptibility gene, is associated with viral encephalitis, an Alzheimer’s disease risk factor. Clinical Neurology and Neurosurgery. 233. 107984–107984. 3 indexed citations

Lehrer, Steven & Peter H. Rheinstein. (2022). Alignment of human KAT2A (GCN5) histone acetyltransferase and SARS‐CoV‐2 Orf8 viral proteins. Chronic Diseases and Translational Medicine. 9(3). 263–265. 1 indexed citations

Lehrer, Steven & Peter H. Rheinstein. (2022). Association of cannabis with chronic obstructive pulmonary disease and COVID‐19 infection. Chronic Diseases and Translational Medicine. 8(3). 238–241.

Lehrer, Steven & Peter H. Rheinstein. (2022). Genome‐wide association study of dermatophytosis in the UK Biobank cohort. Journal of the European Academy of Dermatology and Venereology. 36(12). 2482–2487.

Lehrer, Steven & Peter H. Rheinstein. (2022). Shingles vaccination reduces the risk of Parkinson's disease. Chronic Diseases and Translational Medicine. 9(1). 54–57. 3 indexed citations

Lehrer, Steven & Peter H. Rheinstein. (2022). EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer. Cancer Treatment and Research Communications. 32. 100595–100595. 4 indexed citations

10.

Lehrer, Steven & Peter H. Rheinstein. (2022). α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis. Journal of Proteins and Proteomics. 13(2). 109–115. 3 indexed citations

11.

Lehrer, Steven & Peter H. Rheinstein. (2022). Cannabis smoking and age-related macular degeneration in the UK Biobank cohort. Journal Français d Ophtalmologie. 45(7). 756–761. 2 indexed citations

12.

Lehrer, Steven & Peter H. Rheinstein. (2021). BIN1 rs744373 SNP and COVID‑19 mortality. World Academy of Sciences Journal. 3(2). 7 indexed citations

13.

Lehrer, Steven & Peter H. Rheinstein. (2021). Common drugs, vitamins, nutritional supplements and COVID‑19 mortality. PubMed. 2(1). 3 indexed citations

14.

Lehrer, Steven & Peter H. Rheinstein. (2020). Statins combined with niacin reduce the risk of peripheral neuropathy. PubMed. 1(1). 4 indexed citations

15.

Lehrer, Steven & Peter H. Rheinstein. (2020). Alignment of Alzheimer's disease amyloid β‑peptide and klotho. World Academy of Sciences Journal. 2(6). 1–1. 20 indexed citations

16.

Lehrer, Steven, Peter H. Rheinstein, & Kenneth E. Rosenzweig. (2018). Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients. Clinical Neurology and Neurosurgery. 172. 112–115. 6 indexed citations

17.

Lehrer, Steven, Peter H. Rheinstein, & Kenneth E. Rosenzweig. (2018). Allergy may confer better survival on patients with gliomas. Clinical Neurology and Neurosurgery. 177. 63–67. 16 indexed citations

18.

Rheinstein, Peter H., et al.. (1997). Children and tobacco: the FDA's final rule.. PubMed. 55(4). 1441–4. 2 indexed citations

19.

Rheinstein, Peter H., et al.. (1995). Children and tobacco: the Clinton administration proposal.. PubMed. 52(4). 1205–8. 3 indexed citations

20.

Oliver, Richard L., et al.. (1984). A Study of Physicians' Perception of Advertising Judged Deceptive By the Fda. ACR North American Advances. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact